7-2543623-T-G

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_152743.4(BRAT1):​c.770A>C​(p.His257Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000138 in 1,526,924 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000015 ( 0 hom. )

Consequence

BRAT1
NM_152743.4 missense

Scores

6
12

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.12

Publications

2 publications found
Variant links:
Genes affected
BRAT1 (HGNC:21701): (BRCA1 associated ATM activator 1) The protein encoded by this ubiquitously expressed gene interacts with the tumor suppressing BRCA1 (breast cancer 1) protein and and the ATM (ataxia telangiectasia mutated) protein. ATM is thought to be a master controller of cell cycle checkpoint signalling pathways that are required for cellular responses to DNA damage such as double-strand breaks that are induced by ionizing radiation and complexes with BRCA1 in the multi-protein complex BASC (BRAC1-associated genome surveillance complex). The protein encoded by this gene is thought to play a role in the DNA damage pathway regulated by BRCA1 and ATM. [provided by RefSeq, Mar 2012]
BRAT1 Gene-Disease associations (from GenCC):
  • neonatal-onset encephalopathy with rigidity and seizures
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, ClinGen, G2P, Labcorp Genetics (formerly Invitae)
  • neurodevelopmental disorder with cerebellar atrophy and with or without seizures
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.2402257).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_152743.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRAT1
NM_152743.4
MANE Select
c.770A>Cp.His257Pro
missense
Exon 5 of 14NP_689956.2
BRAT1
NM_001350626.2
c.770A>Cp.His257Pro
missense
Exon 5 of 14NP_001337555.1
BRAT1
NM_001350627.2
c.245A>Cp.His82Pro
missense
Exon 4 of 13NP_001337556.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRAT1
ENST00000340611.9
TSL:1 MANE Select
c.770A>Cp.His257Pro
missense
Exon 5 of 14ENSP00000339637.4
BRAT1
ENST00000421712.1
TSL:3
n.*115A>C
non_coding_transcript_exon
Exon 3 of 5ENSP00000409209.2
BRAT1
ENST00000467558.5
TSL:5
n.786A>C
non_coding_transcript_exon
Exon 4 of 10

Frequencies

GnomAD3 genomes
AF:
0.00000659
AC:
1
AN:
151840
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000264
AC:
5
AN:
189680
AF XY:
0.0000394
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000393
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000625
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000341
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000145
AC:
20
AN:
1375084
Hom.:
0
Cov.:
33
AF XY:
0.0000178
AC XY:
12
AN XY:
673752
show subpopulations
African (AFR)
AF:
0.0000323
AC:
1
AN:
30996
American (AMR)
AF:
0.0000287
AC:
1
AN:
34900
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
21146
East Asian (EAS)
AF:
0.0000264
AC:
1
AN:
37916
South Asian (SAS)
AF:
0.00
AC:
0
AN:
73548
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49508
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5338
European-Non Finnish (NFE)
AF:
0.0000160
AC:
17
AN:
1065180
Other (OTH)
AF:
0.00
AC:
0
AN:
56552
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.447
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000659
AC:
1
AN:
151840
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
74130
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41328
American (AMR)
AF:
0.00
AC:
0
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3460
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4792
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10562
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
67954
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.0000539
Hom.:
0
ExAC
AF:
0.0000249
AC:
3

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Neonatal-onset encephalopathy with rigidity and seizures Uncertain:1
Jun 13, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces histidine, which is basic and polar, with proline, which is neutral and non-polar, at codon 257 of the BRAT1 protein (p.His257Pro). This variant is present in population databases (rs201957861, gnomAD 0.007%). This variant has not been reported in the literature in individuals affected with BRAT1-related conditions. ClinVar contains an entry for this variant (Variation ID: 540158). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.099
BayesDel_addAF
Benign
-0.028
T
BayesDel_noAF
Benign
-0.10
CADD
Benign
17
DANN
Benign
0.94
DEOGEN2
Benign
0.052
T
Eigen
Benign
-0.17
Eigen_PC
Benign
-0.25
FATHMM_MKL
Benign
0.43
N
LIST_S2
Benign
0.71
T
M_CAP
Uncertain
0.13
D
MetaRNN
Benign
0.24
T
MetaSVM
Uncertain
0.13
D
MutationAssessor
Uncertain
2.1
M
PhyloP100
2.1
PrimateAI
Benign
0.44
T
PROVEAN
Uncertain
-4.1
D
REVEL
Uncertain
0.41
Sift
Uncertain
0.021
D
Sift4G
Benign
0.10
T
Polyphen
0.022
B
Vest4
0.41
MutPred
0.48
Gain of loop (P = 0.0079)
MVP
0.79
MPC
0.068
ClinPred
0.34
T
GERP RS
3.3
Varity_R
0.43
gMVP
0.57
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201957861; hg19: chr7-2583257; API